173 related articles for article (PubMed ID: 34283067)
1. Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040.
Oddone E; Bollon J; Nava CR; Consonni D; Marinaccio A; Magnani C; Gasparrini A; Barone-Adesi F
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283067
[TBL] [Abstract][Full Text] [Related]
2. Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use.
Oddone E; Bollon J; Nava CR; Bugani M; Consonni D; Marinaccio A; Magnani C; Barone-Adesi F
Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31963601
[TBL] [Abstract][Full Text] [Related]
3. Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years.
Lin RT; Chang YY; Wang JD; Lee LJ
J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):463-470. PubMed ID: 30072200
[TBL] [Abstract][Full Text] [Related]
4. Past trends and future prediction of mesothelioma incidence in an industrialized area of Italy, the Veneto Region.
Girardi P; Bressan V; Merler E
Cancer Epidemiol; 2014 Oct; 38(5):496-503. PubMed ID: 25200195
[TBL] [Abstract][Full Text] [Related]
5. Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models.
Marinaccio A; Montanaro F; Mastrantonio M; Uccelli R; Altavista P; Nesti M; Costantini AS; Gorini G
Int J Cancer; 2005 May; 115(1):142-7. PubMed ID: 15645436
[TBL] [Abstract][Full Text] [Related]
6. Asbestos Consumption and Malignant Mesothelioma Mortality Trends in the Major User Countries.
Gariazzo C; Gasparrini A; Marinaccio A
Ann Glob Health; 2023; 89(1):11. PubMed ID: 36819965
[TBL] [Abstract][Full Text] [Related]
7. Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016.
Thomas A; Karakattu S; Cagle J; Hoskere G
Cureus; 2021 Apr; 13(4):e14605. PubMed ID: 34040906
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
[TBL] [Abstract][Full Text] [Related]
9. New DNA Methylation Signals for Malignant Pleural Mesothelioma Risk Assessment.
Cugliari G; Allione A; Russo A; Catalano C; Casalone E; Guarrera S; Grosso F; Ferrante D; Sculco M; La Vecchia M; Pirazzini C; Libener R; Mirabelli D; Magnani C; Dianzani I; Matullo G
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071989
[TBL] [Abstract][Full Text] [Related]
10. Clustering of malignant pleural mesothelioma in asbestos factories: a subgroup analysis in a 29-year follow-up study to identify high-risk industries in Taiwan.
Lee LJ; Lin CK; Pan CH; Cheng Y; Chang YY; Liou SH; Wang JD
BMJ Open; 2018 Dec; 8(12):e021063. PubMed ID: 30530573
[TBL] [Abstract][Full Text] [Related]
11. Gene-asbestos interaction in malignant pleural mesothelioma susceptibility.
Tunesi S; Ferrante D; Mirabelli D; Andorno S; Betti M; Fiorito G; Guarrera S; Casalone E; Neri M; Ugolini D; Bonassi S; Matullo G; Dianzani I; Magnani C
Carcinogenesis; 2015 Oct; 36(10):1129-35. PubMed ID: 26139392
[TBL] [Abstract][Full Text] [Related]
12. Non-occupational malignant pleural mesothelioma due to asbestos and non-asbestos fibres.
Proietti L; Spicuzza L; Di Maria A; Polosa R; Sebastian Torres E; Asero V; Di Maria GU
Monaldi Arch Chest Dis; 2006 Dec; 65(4):210-6. PubMed ID: 17393666
[TBL] [Abstract][Full Text] [Related]
13. Pleural mesothelioma and lung cancer: the role of asbestos exposure and genetic variants in selected iron metabolism and inflammation genes.
Celsi F; Crovella S; Moura RR; Schneider M; Vita F; Finotto L; Zabucchi G; Zacchi P; Borelli V
J Toxicol Environ Health A; 2019; 82(20):1088-1102. PubMed ID: 31755376
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma.
Yasumitsu A; Tabata C; Tabata R; Hirayama N; Murakami A; Yamada S; Terada T; Iida S; Tamura K; Fukuoka K; Kuribayashi K; Nakano T
J Thorac Oncol; 2010 Apr; 5(4):479-83. PubMed ID: 20357617
[TBL] [Abstract][Full Text] [Related]
15. Pleural mesothelioma: forecasts of the death toll in the area of Casale Monferrato, Italy.
Furlan C; Mortarino C
Stat Med; 2012 Dec; 31(29):4114-34. PubMed ID: 22829461
[TBL] [Abstract][Full Text] [Related]
16. Forecast of Malignant Peritoneal Mesothelioma Mortality in Italy up to 2040.
Oddone E; Bollon J; Nava CR; Minelli G; Imbriani M; Consonni D; Marinaccio A; Magnani C; Barone-Adesi F
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33379304
[TBL] [Abstract][Full Text] [Related]
17. CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.
Kettunen E; Savukoski S; Salmenkivi K; Böhling T; Vanhala E; Kuosma E; Anttila S; Wolff H
BMC Cancer; 2019 May; 19(1):507. PubMed ID: 31138176
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
[TBL] [Abstract][Full Text] [Related]
19. Incidence of malignant pleural mesothelioma due to environmental asbestos fiber exposure in the southeast of Turkey.
Senyiğit A; Babayiğit C; Gökirmak M; Topçu F; Asan E; Coşkunsel M; Işik R; Ertem M
Respiration; 2000; 67(6):610-4. PubMed ID: 11124642
[TBL] [Abstract][Full Text] [Related]
20. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W
Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
